OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
OP23 评估upadacitinib作为中重度活动性溃疡性结肠炎患者诱导治疗的疗效和安全性:来自3期U-ACCOMPLISH研究的结果
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjab075.022
Khan, Nabab; Vermeire, S; Danese, S; Zhou, W; Pangan, A; Greenbloom, S; D’Haens, G; Panes, J; Juillerat, P; Lindsay, J O; Loftus Jr, E V; Sandborn, W J; Reinisch, W; Sanchez Gonzalez, Y; Huang, B; Xie, W; Liu, J; Weinreich, M A; Panaccione, R